<SEC-DOCUMENT>0001178819-24-000102.txt : 20240920
<SEC-HEADER>0001178819-24-000102.hdr.sgml : 20240920
<ACCEPTANCE-DATETIME>20240920125705
ACCESSION NUMBER:		0001178819-24-000102
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240920
FILED AS OF DATE:		20240920
DATE AS OF CHANGE:		20240920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALAMOS GOLD INC
		CENTRAL INDEX KEY:			0001178819
		STANDARD INDUSTRIAL CLASSIFICATION:	GOLD & SILVER ORES [1040]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35783
		FILM NUMBER:		241312611

	BUSINESS ADDRESS:	
		STREET 1:		181 BAY STREET
		STREET 2:		SUITE 3910
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5J 2T3
		BUSINESS PHONE:		416-368-9932

	MAIL ADDRESS:	
		STREET 1:		181 BAY STREET
		STREET 2:		SUITE 3910
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5J 2T3
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kalamosgoldhelpstocreate.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ieb85d381ba744abeb1ad60cc107285fa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">Washington, D.C. 20549</font></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">Form 6-K</font></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">PURSUANT TO RULE 13a-16 OR 15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">For the month of September, 2024</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Commission File Number&#58; 001-35783</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:144%">Alamos Gold Inc.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(Translation of registrant&#8217;s name into English)</font></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Brookfield Place, 181 Bay Street, Suite 3910</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Toronto, Ontario, Canada</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">M5J 2T3</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive office)</font></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Form 20-F&#160;&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:144%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form 40-F&#160;&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:144%">x</font></div><div style="margin-top:9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">EXHIBIT INDEX</font></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.877%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EXHIBIT</font></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NO.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DESCRIPTION</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Press release&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="ex991alamosgoldhelpstocrea.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Alamos Gold Helps to Create Inaugural Research Chair to Better Detect and Treat Gastrointestinal Cancers</a><a href="ex991alamosgoldhelpstocrea.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, September 20, 2024</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">SIGNATURES</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alamos Gold Inc.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; September 20, 2024</font></div></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Scott K. Parsons</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott K. Parsons</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Corporate Development &#38; Investor Relations </font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991alamosgoldhelpstocrea.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i7e2a034bde1d474c8a9514373d479c0e_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000080;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div></div><div style="padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.985%"><tr><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.897%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt"><img alt="logo2a23a.gif" src="logo2a23a.gif" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:40px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2.25pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:100%">Alamos Gold Inc.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brookfield Place, 181 Bay Street, Suite 3910, P.O. Box #823</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Toronto, Ontario  M5J 2T3</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Telephone&#58; (416) 368-9932 or 1 (866) 788-8801</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.695%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Alamos Gold Helps to Create Inaugural Research Chair to Better Detect and Treat Gastrointestinal Cancers</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Toronto, Ontario (September 20, 2024) &#8211; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Alamos Gold Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TSX&#58;AGI&#59; NYSE&#58;AGI</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) (&#8220;Alamos&#8221; or the &#8220;Company&#8221;) is proud to announce a significant contribution to The Princess Margaret Cancer Foundation to create the new Alamos Gold Chair in Gastrointestinal Surgical Oncology. The Company&#8217;s $2 million contribution over ten years will support the new Chair in making a meaningful impact on cancer research aimed at better understanding, diagnosing, and treating gastrointestinal cancers.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Last month, Dr. Catherine O&#8217;Brien was named the inaugural Alamos Gold Chair in Gastrointestinal Surgical Oncology by Princess Margaret Cancer Centre at University Health Network, University of Toronto. The appointment is for an initial five-year term, effective August 1, 2024.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;This funding represents a significant step forward in the research of gastrointestinal cancers,&#34; said President &#38; CEO John McCluskey. &#34;By supporting advanced research, the new Chair will aim to improve early detection, develop more effective treatments, and ultimately save lives. This investment will enable researchers to explore new avenues and make breakthroughs that can transform the outlook for those affected by these cancers.&#34;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gastrointestinal cancers encompass a variety of cancers affecting the digestive system. Specifically, this funding will focus on cancers of the stomach, liver, pancreas, colorectal region, esophagus, and small intestine. These cancers collectively pose a significant health challenge, accounting for a substantial proportion of cancer diagnoses in Canada.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">According to recent statistics, gastrointestinal cancers are diagnosed in over 30,000 Canadians each year. Colorectal cancer alone accounts for approximately 26,000 of these cases, making it one of the most commonly diagnosed cancers in the country. Pancreatic cancer, known for its aggressive nature and low survival rates, affects about 6,000 Canadians annually. Stomach, liver, and esophageal cancers also contribute to the overall burden, with thousands of new cases diagnosed each year.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The research initiatives supported by this funding will include clinical trials, biomarker discovery, and studies into the genetic and environmental factors contributing to gastrointestinal cancers. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;We applaud Princess Margaret Cancer Centre for making a meaningful impact to reduce the impact of cancer here in Canada and internationally. This new Research Chair can advance the understanding of gastrointestinal cancers and bring hope to patients and their families,&#8221; added McCluskey.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000080;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:120%">TRADING SYMBOL&#58; TSX&#58;AGI   NYSE&#58;AGI    </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Alamos</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Alamos is a Canadian-based intermediate gold producer with diversified production from three operations in North America. This includes the Young-Davidson mine and Island Gold District in northern Ontario, Canada, and the Mulatos District in Sonora State, Mexico. Additionally, the Company has a strong portfolio of growth projects, including the Phase 3+ Expansion at Island Gold, and the Lynn Lake project in Manitoba, Canada. Alamos employs more than 2,400 people and is committed to the highest standards of sustainable development. The Company&#8217;s shares are traded on the TSX and NYSE under the symbol &#8220;AGI&#8221;.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About The Princess Margaret Cancer Foundation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Princess Margaret Cancer Foundation is Canada&#8217;s largest and leading cancer charity, dedicated to raising funds for Princess Margaret Cancer Centre, one of the world's top 5 cancer research centres known for its game-changing scientific achievements and exceptional patient treatment and care. Through philanthropy, events, our world-leading home lottery program, and commercialization initiatives, we make possible the critical funding required to accelerate cancer research, education, and clinical care -- benefitting patients at Princess Margaret Cancer Centre, throughout Canada and the world. </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.thepmcf.ca</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR FURTHER INFORMATION, PLEASE CONTACT&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.710%"><tr><td style="width:1.0%"></td><td style="width:78.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Scott K. Parsons </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Senior Vice President, Corporate Development &#38; Investor Relations </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(416) 368-9932 x 5439 </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Khalid Elhaj</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vice President, Business Development &#38; Investor Relations</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(416) 368-9932 x 5427</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ir&#64;alamosgold.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Kenzie Broddy</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Director, Communications</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Princess Margaret Cancer Foundation</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">437.215.6961</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Kenzie.broddy&#64;thepmcf.ca</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The TSX and NYSE have not reviewed and do not accept responsibility for the adequacy or accuracy of this release.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2 &#124; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALAMOS GOLD INC</font></div><div style="padding-right:18pt"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo2a23a.gif
<TEXT>
begin 644 logo2a23a.gif
M1TE&.#EAK0&[ ?<      'A<6'5G7FIN<75L97-R<)]6*YE7-)IC+;Y:'[Y9
M([MB&ZIB*:=G.+=G*K1G-[QP-(%B28ML58ES5YEK29=S5HQV9J9J0Z1R3*MP
M1+!L1[U[2;Q]4\=;!]E<&LIE%]YI"MAJ&-]P%]QQ'L=K)\QQ*\AV-MUL--IU
M*-1T.-1Z,]-].]UU-MYU/-Q\,]I^.>EJ"N5M$NIS#NIU&?ML OAM%/9R ?1Q
M"_9Z!/1[#?YS OYU"_YY OYY#?-T$_-U&?5Z%?5Y&OYV$OMV&_QX$_EY&>EZ
M)^1[-/1U(_-W*?)[(O-[*OQT(OI\(?E[*?5_,L=]1LMW4MA[1NE[0YZ :+^
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M<Q1CHN]>PP0FH,^(K5E>$B>BQ26N#T ^*,(DF.&7*M9G?P*966O V!HE4"J
M9525#6A 'AX"8(P2R:,@,62X&:2A%LUH8T':F#=V#3*(2_(CN0 9D4=:,D8[
M ,,-4) (9)QC(/E[XV%LZ!-)T?&2U/K8 B29+DI"!)6P+),.>#"&&;QA$O8P
MUC]B]A5_H.,??"HB\/)XN/.0B0@,8.7N7.F06,:2.6) @1MJH32]P2DA8'%F
M>6@P ]4H$WK,;(@VM4B7*UA!%-OP2#XL9R5"N<0OA@)FAIQ3GO0=[CG"')MY
M7O/_GV\^+)SB'&?Y;D $NX C+_4A&4X8J;]1"F120#-/V&0DA!L8D C^I!E
M&2+02?&I!IB !=6V@[?MR?,\/VA"$WX .:V(P9L9Q=E&%])15;W!%=D0R+;^
ML=/XP-%*)X5I3%,XTX345'U!0!D-AC $9&RCEU;\J4(%,]6$##5K137J41]W
M2HIE+ C9F%*QJOH94:X$+RG9I42N&K&L(F2KG1,F<[:A#1M.!2$I4I:W#@.A
M@.EF&;B A!AF<-'S1(</E"/K0=@J+[<>!*Z>.V,6B1"=<VQC)?<YBF&F4I3[
ME(,5!32<D\ 6M$J51YA_P(4-KYF0'3(678XU"&2#:!D=_SAA#.-X*GVJ>1#B
MK"5O0K+@/2PA!AA<Z+1=K1TA*">P*_'E;3K\QVO!%=N"S/:1/PC"&-)P#KS<
M8YU5%9)B!-(,7*1A!O\ICQ#.QC$0[H N^'I$VQA3)8>L0[K^K"Y!KJM-NIQ!
M$'A;)Y5X@D%E^(&_ 7*$,%:RSETZ]YION^\&]3L0!&^U@/]% ^BXFEP$"^%P
MCUA&H7B2V8- %[KX12*%@VKA%KM8;I-8,$(%5D6K$I7"+\ZQCNUUN$@PPX9K
MU>B*=TSD(@MNC7A#$17S5A#H-FS%+#:RE*<L2R.RXL<W])+;XKA,'%/YRV"V
M%RL2B5 EUQ@AHQMRF-?,9E094?\6S:!O?5]7D#]&UZW^R;.>]\SG/OOYSX .
MM* '3>A"&_K0B$ZTHA?-Z$"?)\^U8(9'%).63PU*L1O]E:8WS>E.>_K3H ZU
MJ$=-ZE*;^M2H3K6J5\UJ5HN0.CHH(/;N"N5:VQJ0\*R27] QC$MP@]:W#K8*
M5>286?!!DW-@QDX")NQF'\O2M:E'.8[!AAG,Y0PA  4Z&NSL;A\+'>,0B# >
M(4P@!"&:H="&0G_J[7:3R!_GP(9X(!@='MB;!T<0PRA:9AI_E-C= /?1?0)K
M&=6@[X[^:<$1<I%!??04R &/.$DO[:#N':*;J@$" 5]D!(Z)H0L,E[C(WP-=
MSD9(%>C_XT&O^# ,A!+)G2./N5E2E"+\<0\=DA!$\.S%!SYPHR@Z$J7,AUZ6
MF&$0-6-0PC'YI(3@T24Z4" $L1)*]*J/):__V)$\,$@+/^3+<?YI@R.DLJV5
M8)!U<[:ZVAFDHGGL\A[E$(9XB!:@#D>TCC-PPR3(,>.U^[TI^3B'.G"AB*7[
MC@9PF(0^!"(/;;'V[Y"/"4HD- @7"' ''  &PGC*3HA'_O/6[.N!TB+X941"
MLJH) KZ**2G_%- \1MA$,$X"<]#;_B(1*@<DM#@'80#[]L#O;7V*8W/\+&,2
M0!1<=#K<FE @@]VD0W'P%5404B&?6FBK&!Y5%0IL% \_QR(8_UOH00\N3_?\
MZ)^7:M!61!KA[E?XJEVP7.""5)1C*IC>5!%HD&]M:(.W!I%^ HA^C],#8(!>
MZU4$/4-"E9(VU()Z1' $JO!)CQ<]JE% !50Q=/$#;+ -YQ!/!6%R'C& )+@\
M >(T'*-/J.* JI&"Y\$'NU 4Q7$\@%1:&%-8<U0$-< 'D^"!T+=E_%."0B@Q
M 7)WK5$V91,X$Y6$Y7$$&*5+L>4X[P4&-, 'MZ .Z.!V>"40MY%B0_B%YO(_
MJ&1O 2( DZ1FS6,98Q #D,!&Z%"! 0B&YT<"_+4N4!9$^3(#2W!EDU8E6*=6
M_R /7BB'RM,!VK1]800O=U@^+'@>/?] !$)@!&=@/P$C= 1Q7UM&B%GC-=31
M8D^&AK#$ \]A!(EP#-EC4C3G4.NDB>IW74;8&A<P,XOX2/%'2)72!9*@#=G3
M4 6!B>;'BG4$5_AB,@#2 %@SBPC6!&-@&6D@"2E!:7Y(<[OT-CQQ?@[@&LR'
M2M"R:0"" 'V#C#O&&ONW7*1"C=%X$ W6/W/4+-F81\^QC;H3.^#X90S("L*P
M'FJ1BAZ164Z6-4>H8TG@!#RP1V#4/_/89IT8@6)0"\N 0<5SCB8VB._B0VAT
MA,_RBK.E3 >)D.RH V)@!M@0;NV$5_[F;X-8'CS@'Q_4CAV57.^5B#&UD1S)
M)X4T _2CBXS_I!"C$F4YYC05@'XR.9-*HB%&P >*( Y AT,.YA >0A*2\E[R
MTT(XF'$1-81!*90^, 9&, )[X'O^P"@SL1-W=4ETQ(I7^65?P -"D0OG0'-0
M:!3ML0Y>466G=#9VV2]\)%2LN#B@^&4QL *0P'>W H=F(0]S^6AY]C%W5$@;
MMI>MU)<Y-@-Y<(^>4GO 86G<DA\84I6.V2YG*5!!X&,L\R,-)21^T9GQ\IDU
MI9(Z4 370Q)*:46&HBT]XEJH:2ZJZ4QETXATL5YB8 3+P$9O.1J'40[A@0+T
MU ;+ ( (D8ZWF9L[]F$TH%W^UR7YQQ$/UB!J,0N#$ -*L&$ @B_X__(:-# &
M<#!?%$&(T,E?0/!H4YF0+L '$L*<,^$1YZ -@B &>1F>^5(IM3A/E@$&<+"<
MY)"> KB>'"D$AC,&8S 2FT62,9.*O41XA*4^MP,_AU,';8,/OH4W#,%6"$IE
M36)8Y]&:1> "@X"3P[F4V.(1Y; -DO "AK=^2X@Q#-150D #*G<#CK"<*ZH0
M[B"1XA.B0OEH)1HY@E .'^@M]E .M5"A1$8#C\BC(K9;CJ%88@2915H[$%@>
M3&@>CWA=_I*C*D<#CB"<>B-]!/$W1+JE;AI7C^@#C_!C5NJA"W&,6OJF>HJA
M744#7R $/L"'EMD0;96G>WJHQ 0&/G #5_]&2E=*F$+*+FV*J)1:.ZRG&A8R
M!($J:8.:$)AHAX9:J:(:2W&QJ8YJIPHC+I,ZJJPJ0$]W'E_P X%Z?YTJ$"BV
M> :AI@#5JKS:8K/TG6.&-]<Y?<1*K+[%+3DT$/>P"[! #K5:K-"*%)MU)1[!
M#*E !W3@#Q\"A-':K4R!&%5B"9 P R!0"W7EK>CJ%,+%"'*A WHW$(((J>DZ
MKQ(Q'WB3%LS #(>  C$P!BB  MA#KP);$U1#1?#P*%0(-#J:'ED'%:NU5P,;
ML13A%?4A#*Q 4.\5!!A(#;KTARPJL2 +$;CP!U(*04\G [UW(*/7+04+@B$+
MLJ 2%>.P",OA S/_  8\0#?\!X-Y@:LO^[,@4A_,< QK,!<\X$ Y  9T@39;
MD M=XK) &[7TM1+'MX:I]RO^01DFX'.Z1)]2^[*WD CHLQS.L0,%Q!QT$0K'
ML(]]X7+#]Z-?&WR-P5=Z85F2P ?HXS2:QAJLL0)_P'=Q^[7"N@\2(@BJ8@1C
M\ G;X+#R&KC>>B5..@8_%$*"D!+'L6QPZ[C1:FG9D N00RU*, IN(BIJ026:
MVZTAP@_G< ZT\ >OUBM0, GCD$'TE:RGJW;#R@^^= Z3\ :-R"==T 432!_K
MP8NW"WDKVSIP)W=&0'?E 8'!8@1NP HK\3;Z^*S'2W3[0[6L4$LL64^8_T$#
M-/"=O$ 29W8Y6.*UV>MM>K$/Z#!XXXIQR1<C2Y $<$!-;SFLZQMS;$$JQ&4A
MA$23/7 $@+ +ZG </7%V2[:_VCLP#F*?V, &.Y DO<)4YW$$*$ (V0%45F2[
M#%QU][ -R, &<C.,)6H$@E ,Z9 _/+4M?$&;G??! &<G5#L)Z>,[1I $O;<2
MCM>X,BQR*3&RSBM_*'P-M'N^/RQQ-982Y: -K. &;M9AZ54>8P #FK"XENAY
M2>QMVWL/\38(= @_-% $;# <Q3%>#J:^6PQ0#963;<L,LG &IG.14ZP:+H *
M_Y>Y:^QL(<)9@74O*@A1Y_$&D& /7YEV>]QMQ?\Q8AXQ"7^P1$H0"I_D8.":
MR.VF(_6@#MEP"&13.],K$-RV+'ILR8#DL?H!=[_0/!Q3Q["G"WS';*2\8GT%
M9(TB# "T?JWQGZ83!ZR@J[$<;'V5&J-%HJOWO9(2<CY\+/C@R[_\$/F0#RM!
M+3IPD1?J.+*@Q=&#(O=PF]S,2C3ZB*R,B/RIRQF"#+2;S;7'POZP+=W<SIO3
M *I1S&6[C7?D.5T5!)X@8^"%R,ER H%P#&QTSBVLQ>Y<T#@3SQMHEYI6H^(,
MNW^ #+]$25HQ!D,@!88P#C"SP ;!;9%JT![M+NHS [-4-N)I.$5TD;URJ:HQ
M X- .2;5$S]8*R:#,2K_E0*0@ UMV7<D^=$\G2X 9%I$$#:HPEZ_&R F8"U0
MB+UP\QS144 R$CR F59!\BG^5HT]S=,9<C8VV-!':#'_0=3^8@3=1[PUE\S'
M@H06@Y<T,+T>R%M=<M6W"<\E*D2!G"%^%B" F4ML$<H/K-1+LX2R-"9U@+\&
M434<#==@J"IWA-8TVBO1P3')10+@4@_W82!TZTJ"LP-0$P>U<':U>Z>(/5V&
M>$DYD ._^P#CLJIRP0/[EUH Z%"_&-J2-$[)-0&X&:IRX]5SJ@Z3+'[[P&VR
M'3X,<,O:M$JPA=N"XZ=&$ *C0!+$-B@ZE:O!_3<(9MN@ZF4,]%XS8 21IDY:
M_S;=!PU+&U<FQMAE^K5$\&4$>Z@-O_<5NY19; '>#B.&_&7=BHC<YC-/+UD$
MQ="62^:P'UMG\@W206UA%+ PJCTXTO%A&9)4.H ";% -E\40TC?@Y3(!N"Q+
MXT0 #I/@M9,O'BD(V*!;)!F'T[UC$N/AS@,Y-$"*U> ]CS<550,^'GV-!5Y3
MK/&>,)GB^.U>^KT#8U"YOP7@IMS1A!C&8?J\74I,1G3#YB%3/<Y"^&37AL,'
MDG MPC<001J$7RC7=6W,3.0%7A @6J/B2[1>/@ #?& )-13#MEL; VCC&*F;
M5RO41\0U9EY&D$,7@T +J+I(5=,.-)Y1_]A1[ZB 2_]>'FP:Y5LU2^(["+>0
M:X8"1\[)0T33!$XN+:P\2/BB:=("(/:]Z-AM9.)8 X0@8UJ8$ ]GY'RSCG/=
M+Y?T,;E3'N4MCXR.8&&*/JHSN MQ-:V>X2WF-)9"'@>>I:,>9G3! R- !JZ
M#9@9)-#-Y7+TZ?V2Y) U!$U 3T00BP9YZSM61&G4"N701J;17+7G,+D,(!A8
MS]>5M*HA 9*4Y['$DDHP2X;4W7F1Y?]P7R@&+U$,Y@*57][^90KH RC\"[3:
MQUL8V^*B7E]:9/T4DP,?9H:S T5@ HK@23'M$89<8K1CI%Z*8%VU \?$6/)>
M9"-- X2,#2E!<;YMGSP9CC+_<GXG_V6LH7<X/3#8E!CU\$L[%AL7=: 3+Y1
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MFE\&IU0MPJB#T$2C!"5\ 0R^&T(17I$.K=KW']!M<(A3"MVMR (.4QJ)*6M
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MVY%(U# 8 =J+&WN;B-)%W@]F" P(B3"0WX(YX?/ T H>5QT( R.@ VP@+HV
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MCP2VA[!93[;FP]<VBI%H@I(@L^5DGSYQ[O+FZ102C5JE@U:@IP:>934F;J)
M;/HV9?M>GQP("0_P3?/.(3"+@P)5AV*>B-JHGJ.HUPXES/4!3@A?'Q^V4#O#
MWYA=U_?N:/@V")&@Z;H]B7QFGJ']\/W6(4%1@AFH@WS5R8@PK+&8(8:XG?B#
M<02B'6=>V>T$<20J@C' .CRHEF[CN9STI]0,"1\@3Q4RPI" 8NY,\B02CK*A
M V,P&<#*[O^7[DN,Y>P# LPCQ\\N3R*.V8$N6(%0P(;#V'&)*'/8F,)<!>_O
M?9()=7,E>A\P,! ZAXCZ^F2)W(I42R)ZH=! OZ)] 8/=$H4#@Q.8GL@-4<(<
M.L[\!G0:5Z+F!2L72(4&]2>7[AET>(D4ZFN1F%)(-Z/C; ,W.-><'&PYQ3CS
MTHD,0L@ZA?4LRDQF@81\Q7/U_-AQN(^G:"$#-LE1]/08_?50+P(@B!Q<,% +
M-XM[V 88XG/P;5R=IM1HUR'*% (C"(-A#W"C[E>TP(EM^ EEQU*7V8'(?G8J
M%7<<,J5:=9H>7\^(DRQWCXI[]ESWB-9[3R'YN! 0JEBT*-7# 'C_E?# <0D=
MQ2UX4$>B0*$!(T@#FONK.0UNC7#6?1@N4K:==S7X Y(/'X"M>'R@=*0)F@*8
MOBGYA#WY_.$!&D !15 7!WJ-@$DPBN@0 =0(3E$N(GZ9T:CWBI=J.U*"0+$"
M5;!*D'3OLJ GY>+V:DX55PL=]ECV*_7 G:WY[>D!^!*#PC$<(WT0G+AZX-/,
MR$83>DV3"TUZ=PW[SJ:!,ZB$<M 9B^,/K+J'!E()I+?6>Y'KT1;;NA]A, A4
M6AB[B9G3&I%EM7]WT$D:<0[KOR#XN47\SI$2&("$61! EZ\+?M_H."D4E7C[
MD'Y[X:!,-$'=S>\>&F";8X%4Z:CZE^P9_WB9?/@CFB?I_6K$7=A'FZO@*Z&7
M(I;IIL/9?4S25)K\#-KA$>X5_I?YG2 %+-L=#\E*3*(WLI.PQ;#VD_>=?@E9
M:I$8 B9H)^QOG:S2X^47B1_@TKQ+F@<>?UTIC<+8R M*3$;_/+6;>\P%B'\"
M!Q(L:/ @PH0*%S)LZ/ A1()$)E*L:/$BQHP:-W+,.(.-L'+[Z$4L:?(D0G_^
M[MT36"_:P(T 9M*L:?,FSIPZ=_+LZ?,G )1"AQ(M6K0CTJ1*ETY4 4E;NI7[
M]AW$9_0J2I4L!<:+MZ\>.G7_*A:9"/0LVK1JU\[$ZO8M7*%,Y])=R@<2N9;_
M^@GD&_=O294I_?^--<OV,.+$:0$S;LRX+N3(%N&PVLK/K^/,$%EN_=<5';I_
MBD>3+EU3,^K4)R6SIAMDQI]:G573+CA5H&"%IG?S7ES[-W")K8=W5*+$1Y$Q
M,^H(X^IUW[W0#6\'WZQ7X%3J!O?%JU=/=._PXF]6+T^;.'J-08+HT$&#QI A
M=( )G/=O)<&IN?-3-1]1.T3C"1B>?P4ZEAZ"%@5AD1!"B('"',>L-$]_!A;5
M67;[[+>05> -^*%B%HH(5X(E9B0$#3TT 0,=QV!7X4!3>=<79B.^U:&'(.KH
MFXT]#F5B@COLL*!%-.C  PHHA(+,AB\"Z*-M_7&F%W5-$M1AASMJ"13_E%V:
M!"2"[4U4%H,3K2='-M'=XT\],'IY4']:W6-*)GGIE4]$6^JITYM]-@1F>CWT
M(*209%:T0WN G! ',^6HDUL_-?:Y%9[_^(+%@V*<L<TY,S[4WYZATN0GJ0D!
MBB"A.S1(9$4ZU# &"D<P-UNI _&C$C)TH" &#13]\49>*(FZ9ZW%QG3J<.M-
M)*0.% EQ$0\-MM!"*-FX]-U>DOK8U3:AS! $#[U6A (??D3DCD!9#KNCL<8B
M^RY&[151!!W,X$F5/80=I)*5;^G'[VW0M<1/5\M,(H888RB1T7KEIKF/?26M
M"V*[Q<)[,8,.'G&'-OE^I5"_J&FX4C4(&V'$_T5"CDDF''&HY"9#ZDXL7L6U
M8GPS12G"4,0=S #XI&,O9R<8/FW>D\T@*ABWD:""N@<&#7#\L<Y 4P)]T,P$
MUDPJSL@J:]&1+J"@QS:Y95A=?_9,XL8.1+1M$1#S+DOH1#R$2\.O(3>4]6Y;
M<]VUUZPJ& 0=YX0SL&IMROF/5?S44L<,,S1[T;QRNZURJ^WI\,8?]OPS8Z4-
M6<4W:7[["3B\EF?.Q1MUE(,.XIK]RQ*NGXQ@1 \I9R3HVV#KT(,.<!#R#S]7
M*T05Z8F9WB?J0 )QT=(6^>"#&"[,44ZPFNE[JS_8A!)K[KL/2JB@K<9+0Q$P
M"'^X2<@GO];R;S:/<?^#T ?11AN=H*.W6_>0T^8_G &'-DRN(CY8S[QXEZJW
MK8=9& $>#'SPASZ4!$;OXU'\?#2_#1*A/4X80RBV@9U_9(\A4\%0=G"CKZET
MYQ[#$(08,B*F!+W!$8>SSTJ$9CS&Y>B"/,E@ESC(P2(,X0@OV$,Y/ 8S@O!O
M(/QR"72JX0@W?$M!\\(<@H)0A#8X8DT _ ?M_+%#@?BP)T"$DA"%V*P8C&$/
MVOC78,P6IR<61"60X,,,%C:X>=4O0>T95!LB0;43<F:,/"PCG\[8HS2FT4A=
M>($H8'>=A51IA5016"WF( 1#.6N3E>MCB7C@'AW4(0XO4J'H>HC(H"C21HS_
M9.0/?C"&,8AB&YVA$,@L68]X"$08CSC911I4N2(T"(LF^F,/ CE(JNBK(51;
MY:A:.:)7-D]P$WG/&Z"0"FW0RB!A/.4_MJ$*(Z#@(@C\I!!2A:P_TL -D?"<
M2? $36E.DYKOBL^S%'01Y+C !:E@1C>=V,R1E0,8?"AG1LB4*E#ZL8 YTT$Z
MX1 )]GU*(,\L(SU%9,^+Q:=W%/$H18KPAC:,0I(;NF1_SC$./J@@GQ^U"+-T
M@+FO(6A>,ZQ(N&+P ^%!!$87?5]&+;31H>H 8:0@Q\=(>(]=_D,>ZCB''_B
M$28,U2*!I"B_Q)C"@O##HJJ<6% -5-6ASN -*U!%_]D(DP^CW6,24$A#,$%:
MU3' H V36%-2PW@;;1V2;V$MT%C3:$TB\""/:/U7+=PP6)0%%FP\( (-["J/
M?Q"2)<;KT$_7]5?_-%:(T6O5&]Y@BGLPHPY'P A-.TL1S>D@#HX YY40@B.P
M;K8\JJWJ#(YPAC%<!'@WO6WF)N(&5J +@,U,R&0',JS:VA:X0F3L1HCT6R+,
MP+D3$5,[*Q,1?%0H5,RMCG4%JQ%U6J1\C37F=2$:M4F4T"&AT]-W@Q/>P+9'
MKD68[E"O*-??_6 &<'A$0O"!HX1H*;[ F2^"$YR1-K#"'O>X#??.IAN*&;@V
M"K[PA>DZ7)5\4:]+),B'*O]L80R3>+ZY@\%P[R4PRWZ8*OH@XWA$?)X2T]BZ
M/-A!.R,!SI"Y&,1:DS%J:BQDYT[.#9/ $SRH,F"%O/BK(0)RD(<LY8TZ]+I"
M&FY]/GRE)?<-RIJ9,IA?V9[!ZJ (/H "*YIH&Q^/QLM?#C.<U2C3B^A .5C^
M#V5AK#PW'RC.?@ZLD5F29##J\,-4<_)9^-SG/S/:GDJ8P9WA@2T/YR=&>E:+
MHAO3Z$U3L\P^8/"+K*9E'B+ZAYD&#*=3S<AF91>V":E0DS%XZK>HNM9JG$@<
M6$&5:'QGR=L1"#0N;<99Q\76QK[9?MT6Z5$;!%VE/@VQ273L::]3!V0VLQMJ
MH6;_@QQZV-%V"[7##2:;SAFF=F[%?RR8R&]C1=SN1EVN!4V5-6G5D#EA-[C?
MK6^,1<X-LA (KP5"Z0E#&]]&V3?"+X;M?U-VQ0]F]J4-?I6$4QQ>[:R%JQ_2
M%HD?I>(>1U8=6 'P7B\DN;+E^)<^KO+AH/=R<,#X/P8MV_X(&.4'7SG.(S/F
MP6);V\>UN:9S+O2YD+OEU,TVT#73H*4SO>E.?SK4HR[UJ5.]ZE:_.M:SKO6M
M<[WK7J=ZQH10!]G<HSN[E)/0DBZ4K[.][6Y_.]SC+O>YQST,1A@[AR&N]H@,
MO>]^Y,&CQ\YB0^[]3WX__'#JVX,9Q #O6BW\4-8C^<E3)K[REK\\YC.O^<US
=OO.>_SSH0R_ZT9.^]*,_68/:8QS!3Q+R)0D( #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
